Therapeutic Asset Ratings
3,187 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Universal Cd19 Car-Γδt Cell
Autoimmune Encephalitis
Tongji Hospital
P1
CC
(43)
Universal Cd19 Car-Γδt Cell
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Tongji Hospital
P1
CC
(43)
Universal Cd19 Car-Γδt Cell
Acquired Idiopathic Inflammatory Myopathy
Tongji Hospital
P1
CC
(43)
Universal Cd19 Car-Γδt Cell
Multiple Sclerosis
Tongji Hospital
P1
CC
(43)
Universal Cd19 Car-Γδt Cell
Myasthenia Gravis
Tongji Hospital
P1
CC
(43)
Universal Cd19 Car-Γδt Cell
Neuromyelitis Optica
Tongji Hospital
P1
CC
(43)
Wu-Cart-007
Adult T-Cell Leukemia/Lymphoma
Washington University School of Medicine
P1
CC
(43)
Wu-Cart-007
Enteropathy-Associated T-Cell Lymphoma
Washington University School of Medicine
P1
CC
(43)
Wu-Cart-007
Hepatosplenic T-Cell Lymphoma
Washington University School of Medicine
P1
CC
(43)
Wu-Cart-007
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
Washington University School of Medicine
P1
CC
(43)
Wu-Cart-007
Primary Cutaneous Gamma-Delta T-Cell Lymphoma
Washington University School of Medicine
P1
CC
(43)
Wu-Cart-007
T-Cell Non-Hodgkin Lymphoma
Washington University School of Medicine
P1
CC
(43)
Wu-Cart-007
T-Cell Prolymphocytic Leukemia
Washington University School of Medicine
P1
CC
(43)
Wu-Cart-007
Mycosis Fungoides
Washington University School of Medicine
P1
CC
(43)
Wztl002-1
B-Cell Non-Hodgkin Lymphoma
Malaghan Institute of Medical Research
P1
CC
(43)
Wztl002-1
Primary Mediastinal Large B-Cell Lymphoma
Malaghan Institute of Medical Research
P1
CC
(43)
Wztl002-1
Follicular Lymphoma
Malaghan Institute of Medical Research
P1
CC
(43)
Zi-Ma4-1
Non-Small Cell Squamous Lung Carcinoma
Zelluna Immunotherapy AS
P1
CC
(43)
Zi-Ma4-1
Synovial Sarcoma
Zelluna Immunotherapy AS
P1
CC
(43)
Α-Pd-L1/4-1Bb Dll3 Car-T
Small Cell Lung Carcinoma
Sichuan University
P1
CC
(43)
a2b395
Colorectal Adenocarcinoma
A2 Biotherapeutics Inc.
P1/2
CC
(43)
a2b395
Kidney Cancer
A2 Biotherapeutics Inc.
P1/2
CC
(43)
a2b395
Rectal Carcinoma
A2 Biotherapeutics Inc.
P1/2
CC
(43)
a2b530
Colorectal Adenocarcinoma
A2 Biotherapeutics Inc.
P1/2
CC
(43)
a2b530
Colorectal Neoplasm
A2 Biotherapeutics Inc.
P1/2
CC
(43)
Showing 1651 to 1675 of 3,187 assets
Previous
Page 67 of 128
Next
